Latest Articles
- The genetics, screening, and treatment of epithelial ovarian cancer: An update
Recent advances have improved survival, and a new blood screening test holds promise.
- The Mediterranean diet and endothelial function: Why some dietary fats may be healthy
Some dietary fats, but not others, may impair endothelial function.
- Raloxifene: A new choice for treating and preventing osteoporosis
The pros and cons of estrogen replacement therapy, bisphosphonates, and raloxifene, the first of a new class of selective estrogen receptor modulators.
- Angioplasty and stenting in acute coronary syndromes: Who, when, how, and why
Questions remain about when and how to use these interventions.
- Pancreas transplantation in type 1 diabetes: Hope vs reality
Freedom from insulin injections, but at the price of lifelong immunosuppression.
- Adjunctive medical therapy for acute coronary syndromes
Aspirin, nitrates, beta-blockcrs, ACE inhibitors, statins, and intraaortic balloon pumps all have important roles.
- Primary pulmonary hypertension: Update on pathogenesis and novel therapies
Research into biochemical derangements, and new therapies that prolong survival.
- On this we agree: The value of healthy debate in medicine
The debate on dyspepsia on page 214 illustrates the value of healthy controversy.
- How new technology is changing mammography and breast cancer management
Improved detection now allows a tailored approach to abnormal findings.
- Where to draw the line using statins: Lessons from 4S to AFCAPS/TexCAPS
For patients at low risk, a treatment that is beneficial statistically may not be practical or economical. But how should this question be decided? And who should decide?